PharmaShots | Incisive News in 3 Shots

Subscribe Now

 Sanofi

Regeneron and Sanofi Report the US FDA’s sBLA Acceptance of Dupixent (Dupilumab) to Treat Chronic Spontaneous Urticaria (CSU)

Regeneron and Sanofi Report the US FDA’s sBLA Acceptance of Dupixent (Dupilumab) to Treat Chronic Spontaneous Urticaria (CSU)

November 15, 2024

PharmaShots Weekly Snapshots (September 30 – October 04, 2024)

PharmaShots Weekly Snapshots (September 30 – October 04, 2024)

October 4, 2024

Recordati to Acquire Sanofi’s Enjaymo, Enhancing its Rare Diseases Portfolio

Recordati to Acquire Sanofi’s Enjaymo, Enhancing its Rare Diseases Portfolio

October 4, 2024

PharmaShots' Key Highlights of Third Quarter 2024

PharmaShots' Key Highlights of Third Quarter 2024

October 1, 2024

PharmaShots Weekly Snapshots (September 23 – September 27, 2024)

PharmaShots Weekly Snapshots (September 23 – September 27, 2024)

September 27, 2024

PharmaShots Weekly Snapshots (September 16 – September 20, 2024)

PharmaShots Weekly Snapshots (September 16 – September 20, 2024)

September 20, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us